United Therapeutics
UTHR
UTHR
393 hedge funds and large institutions have $5.72B invested in United Therapeutics in 2016 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 133 increasing their positions, 160 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
393
Holders Change
+10
Holders Change %
+2.61%
% of All Funds
10.5%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.19%
New
46
Increased
133
Reduced
160
Closed
34
Calls
$23.6M
Puts
$38.7M
Net Calls
-$15.2M
Net Calls Change
-$14.5M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$47.2M |
| 2 |
Citigroup
New York
|
+$30.7M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$27.3M |
| 4 |
APG Asset Management
Amsterdam,
Netherlands
|
+$20.9M |
| 5 |
FQ
First Quadrant
Glendale,
California
|
+$17.9M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$100M |
| 2 |
Goldman Sachs
New York
|
-$30.4M |
| 3 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$29.6M |
| 4 |
SCM
Scopia Capital Management
New York
|
-$24.6M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$19.2M |
